Medidata’s Cloud-Based Pharmaceutical Approach May Spur High Gains
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. (More…)
Medidata Solutions (MDSO) is not a company you may have heard of, and with good reason. The computer technology company had its initial public offering in 2009 and maintains a market capitalization of just over a billion dollars. This New York-based firm specializes in providing drug companies software for the clinical development process. Using a cloud-computing approach, the business provides a “software as a service” (colloquially known as SaaS) to help increase the efficiency of various clients’ clinical trials. As there are a plethora of restrictions and protocols a company must adhere to when going through the trial process, it’s vital to ensure all of these regulations are met and done in a proper and well-organized manner to ensure overall legitimacy and increase the
We recommend you visit the following site for more complete information and related topics. Article source: http://seekingalpha.com/article/913911-medidata-s-cloud-based-pharmaceutical-approach-may-spur-high-gains